在患有类风湿性关节炎的生育年龄患者中预防怀孕的最佳证据总结
Sanjiao Liu1, Yifan Guo1, Hua Ren1
1School of Nursing, Shanxi University of Chinese Medicine, Jinzhong City, Shanxi Province, 030619, People's Republic of China.
Journal of multidisciplinary healthcare
|December 31, 2025
概括
这项研究总结了基于证据的建议,对患有类风湿性关节炎 (RA) 的女性进行孕前护理. 它旨在指导医疗保健提供者管理育儿年龄的RA患者,以确保更安全的怀孕和更健康的婴儿.
科学领域:
- 类风湿病学 类风湿病学
- 产科 产科 产科 产科 产科
- 基于证据的实践.
背景情况:
- 风湿性关节炎 (RA) 通常在生育年龄开始,增加妊娠不良结果的风险.
- 目前的临床实践缺乏全面的,基于证据的指导方针,用于RA患者的预孕管理.
- 炎症和RA治疗可能会对怀孕和胎儿健康产生负面影响.
研究的目的:
- 系统地识别和综合最好的现有证据,对 RA 的生育年龄妇女的怀孕前护理.
- 为临床护理实践制定基于证据的指导方针,用于在生殖年期间管理RA.
主要方法:
- 进行了基于证据的资源的系统搜索,包括指南和数据库.
- 搜索使用了"6S"金字塔模型,涵盖了2025年6月17日之前的文献.
- 分析了包含的来源,以提取关于怀孕前管理的建议.
主要成果:
- 包括11个出版物 (3个指导方针,5个专家共识,2个临床决定,1个系统审查).
- 在七个关键领域制定了23个最佳证据建议.
- 十五个建议得到了强烈支持,而八个得到了弱支持.
结论:
- 这项研究提供了关于在育龄期RA患者中预孕管理的最佳证据的综合总结.
- 医疗保健提供者应在将这些建议应用于个体患者需求时使用临床判断.
- 这些发现旨在改善RA妇女的妊娠结果和婴儿健康.
相关概念视频
Rheumatic Heart Disease III: Medical Management
263
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
263
Rheumatic Heart Disease IV: Nursing Management
246
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
246
Genome-wide Association Studies-GWAS
15.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.2K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
439
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
439
Rheumatic Heart Disease I: Introduction
404
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
404
Atherosclerosis III: Management
291
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
291


